Study reveals Naringenin functionalized silver nanoparticles enhance drug delivery in human serum albumin, indicating promising therapeutic properties.
The natural drug, Naringenin (Nar) based synthesis of drug-functionalized silver nanoparticles (AgNPs), has gained much attention in biomedicine owing to its unique optical and therapeutic properties. The present study deals with the biosynthesis of drug-functionalized AgNPs using Naringenin as a capping agent. Further characterization of Naringenin-AgNPs (Nar-AgNPs) was done by a combination of FTIR, XRD & TEM analysis. The TEM analysis revealed that most of the Nar-AgNPs attained a spherical morphology of around 30 nm. The mode of interaction between Nar-AgNPs with human serum albumin (HSA) was explored using a series of spectroscopic, calorimetric and CD analysis. The thermodynamic kinetics, including the binding energy, binding stoichiometry and thermal variations coupled with the AgNPs-HSA complexation, was also evaluated by ITC. The fluorescence spectroscopic study revealed that the intrinsic fluorescence of HSA was significantly quenched upon the binding of Nar-AgNPs. The minor local conformational alterations attained by the secondary structure of HSA when being complexed with Nar-AgNPs were further explored by CD spectral analysis. The comprehensive and better understanding of Nar-AgNPs interactions with medically significant plasma protein, HSA, threw new light towards drug delivery thereby suggesting its diverse applications in nano medicine.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: